1. Home
  2. MUJ vs CSTL Comparison

MUJ vs CSTL Comparison

Compare MUJ & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings New Jersey Quality Fund Inc.

MUJ

Blackrock MuniHoldings New Jersey Quality Fund Inc.

SELL

Current Price

$11.32

Market Cap

620.1M

Sector

Finance

ML Signal

SELL

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$33.31

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUJ
CSTL
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
620.1M
722.8M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
MUJ
CSTL
Price
$11.32
$33.31
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $45.11
AVG Volume (30 Days)
168.0K
★ 320.6K
Earning Date
01-01-0001
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $344,229,000.00
Revenue This Year
N/A
$8.41
Revenue Next Year
N/A
$10.30
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 3.66
52 Week Low
$11.01
$17.72
52 Week High
$12.68
$44.28

Technical Indicators

Market Signals
Indicator
MUJ
CSTL
Relative Strength Index (RSI) 40.07 46.31
Support Level N/A $31.44
Resistance Level $12.44 $34.23
Average True Range (ATR) 0.18 1.78
MACD -0.02 -0.25
Stochastic Oscillator 37.33 4.29

Price Performance

Historical Comparison
MUJ
CSTL

About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.

BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: